Effect of 4-week continuous ingestion of Ripe Kumquats "Tama-Tama" on visceral fat area(VFA) reduction:A randomization open-label,non-eating control comparison group study.

Not Applicable

• Conditions: Healthy adults whose VFA is > =80cm2 and blood serum beta-cryptoxanthin< 50 mcg/d

• Registration Number: JPRN-UMIN000037836
• Lead Sponsor: niversity of Miyazaki

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-08-28
• Study Completion: 2020-03-24
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

1.Subjects who have respiratory, gastrointestinal, hepatic/gallbladder/pancreatic, hematologic, renal, endocrine, cardiovascular and/or mental disease, or who have history of those disease. 2.Subjects who have a serious injury or surgical history within 12weeks prior to this study. 3.Pre-or post-menopausal women having obvious changes in physical condition. 4.Subjects who are at risk of having allergic reaction to citrus foods including kumquat. 5.Subjects who have history of allergic reaction to foods or drugs which needs its treatment or who have possibility of the reaction. 6. Heavy smokers (more than 21 cigarettes per day), alcohol addicts (more than 80g per day alcohol), subjects who are alcohol or drug dependence, subjects who are suspected of alcohol or drug dependence. 7.Subjects who regularly take drugs, foods for specified health uses, foods with function claims and/or supplements, etc. which would affect this study. 8.Subjects donate either 400ml or 200ml whole blood or blood component within four weeks prior to this study. 9. Subjects who are pregnant or lactating, or subjects who expect to be pregnant during this study. 10.Subjects who have cognitive disorder or who have possibility of the disorder. 11.Subjects who participate and take the study drug in other clinical trials within four weeks prior to this study. 12.Subjects who are judges as unsuitable for this study by the principal investigator or subinvestigators.

Study & Design

• Study Type: Interventional
• Study Design: Not specified